 | Up a level |
2022
Mischer, N., Kelber, O., Raskopf, E., Frohne, I, Richter, J. G. and Nieber, K. (2022). Phytotherapy for pain: data from the PhytoVIS study, a NIS in 20,870 users of herbal medicinal products. Planta Med., 88 (15). S. 1561 - 1562. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-0221
2021
Al-Shehab, T., Starck, C., Raskopf, E., Kelber, O., Nieber, K. and Moesges, R. (2021). Gender data from the PhytoVIS study, a pharmaco-epidemiological NIS more than 20.000 patients. Planta Med., 87 (15). S. 1267 - 1269. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-0221
Moeller, J., Kelber, O., Raskopf, E., Nieber, K. and Grundmann, O. (2021). Comparison of epidemiological data on functional GI diseases under an herbal therapy from non-interventional studies in the US and Germany. Planta Med., 87 (15). S. 1267 - 1268. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1439-0221
2020
Becker, S., Zieglmayer, P., Canto, G., Fassio, F., Yong, P., Acikel, C., Raskopf, E., Steveling, E., Allekotte, S. and Moesges, R. (2020). Clinical efficacy and safety profile of allergen-specific immunotherapy using microcrystalline tyrosine (MCT)-adsorbed allergoids - A meta-analysis. Allergy, 75. S. 275 - 276. HOBOKEN: WILEY. ISSN 1398-9995
2018
Liedtke, J. -P., Mandl, A., Koether, J., Chwieralski, J., Shah-Hosseini, K., Raskopf, E., Pieper-Fuerst, U., Allekotte, S. and Moesges, R. (2018). RCAT reflects symptom control and quality of life in allergic rhinoconjunctivitis patients. Allergy, 73 (5). S. 1101 - 1110. HOBOKEN: WILEY. ISSN 1398-9995
Moesges, R., Kasche, E. M., Raskopf, E., Singh, J., Sohlich, L., Astvatsatourov, A., Shah-Hosseini, K., Pirotton, S., Haazen, L., Durham, S. R., Legon, T., Zadoyan, G. and Shamji, M. H. (2018). A randomized, double-blind, placebo-controlled, dose-finding trial with Lolium perenne peptide immunotherapy. Allergy, 73 (4). S. 896 - 905. HOBOKEN: WILEY. ISSN 1398-9995
Moesges, R., Koch, A. F., Raskopf, E., Singh, J., Shah-Hosseini, K., Astvatsatourov, A., Hauswald, B., Yarin, Y., Corazza, F., Haazen, L., Pirotton, S., Allekotte, S., Zadoyan, G., Legon, T., Durham, S. R. and Shamji, M. H. (2018). Lolium perenne peptide immunotherapy is well tolerated and elicits a protective B-cell response in seasonal allergic rhinitis patients. Allergy, 73 (6). S. 1254 - 1263. HOBOKEN: WILEY. ISSN 1398-9995